INmune Bio, Inc.
(NASDAQ : INMB)

( )
INMB After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
MRNAModerna, Inc. 3.27%176.780.0%$746.14m
AMGNAmgen, Inc. 1.08%251.081.5%$612.30m
VRTXVertex Pharmaceuticals, Inc. 3.74%305.531.9%$437.49m
GILDGilead Sciences, Inc. 5.16%66.211.0%$435.11m
REGNRegeneron Pharmaceuticals, Inc. 2.32%643.292.6%$372.05m
ILMNIllumina, Inc. 8.77%226.593.3%$330.40m
SNSSSunesis Pharmaceuticals, Inc. 5.74%4.420.7%$308.97m
NVAXNovavax, Inc. 2.00%42.3075.7%$284.25m
BIIBBiogen, Inc. 0.63%222.381.8%$205.32m
BNTXBioNTech SE 1.33%162.480.0%$158.03m
GOVXGeoVax Labs, Inc. 1.59%2.550.0%$140.51m
BMRNBioMarin Pharmaceutical, Inc. 1.97%96.944.2%$104.96m
CRSPCRISPR Therapeutics AG 1.88%80.140.6%$104.75m
PACBPacific Biosciences of California, Inc. -4.89%8.366.2%$98.27m
MRTXMirati Therapeutics, Inc. -0.06%86.321.6%$96.84m

Company Profile

INmune Bio, Inc. Is a clinical stage biotechnology company, which engages in developing new immunotherapies that reprograms the immune system to fight cancer and Alzheimer’s disease. Its products include pipeline, INKMUNE-Cancer, INB03-Cancer, XPRO1595-Alzheimer and TRD, and LIVNate. The company was founded by Mark Lowdell in September 2015 and is headquartered in Boca Raton, FL.